It is still controversial as to whether Candida spp. are transient or persistent colonizers of the respiratory tract of cystic fi brosis (CF) patients. We conducted a prospective study of 56 CF patients over a 30 month period to assess the distribution and persistence of different Candida spp. In vitro antifungal susceptibility testing was performed and the C. albicans isolates were typed with CARE-2 hybridization and other Candida spp. by RAPD-PCR for persistence and transmission. We found that the mean persistence of the most frequent Candida spp. was Ն 9 months. In patients from whom more than 10 isolates were recovered, we noted that at least 30% were genetically related and transmission of C. albicans in siblings was observed. The majority of all isolates were susceptible to all antifungals tested. We concluded that there was long-term persistence of Candida in the respiratory tract of CF patients and that transmission between siblings may be one possible means of acquisition. Whether long-term colonization with Candida strains can contribute to the chronic infection and infl ammation in the CF lung requires further investigation.
Other Candida spp. are of increasing importance and treatment strategies require consideration of intrinsic resistance. The prevalence of Candida dubliniensis , which is phenotypically closely related to C. albicans , is signifi cantly higher in CF patients than in all other non-HIV infected patients [ 3 ] . The reason for this high prevalence in the CF population is still unknown.
The aim of this study was to investigate the prevalence and persistence rate of different Candida spp. in the respiratory tract of CF patients. Persistence and potential transmission of strains between siblings were further investigated by biotyping.
Materials and methods

Patients
During the 30-month study period, 324 sputa/oropharyngeal swabs from 56 CF patients (29 male, 27 female) being
Introduction
Bacterial and viral infections, fungal colonization, allergic mould sensitization (e.g., allergic bronchopulmonary aspergillosis) and invasive fungal infections are of clinical relevance in cystic fi brosis (CF) patients. Mucus plugging in the lungs, long-term antibiotic treatment, corticosteroid use and surgically implanted catheters are risk factors for colonization of these patients with Candida spp. [ 1, 2 ] . Candida albicans is the most frequent member of the genus isolated from CF patients, but its clinical relevance in CF is still controversial. treated in the Universitäts-Kinderklinik and the Missionsärztliche Klinik in Würzburg/Germany were collected and analyzed. The mean age of the patients was 15 years (range 1-36 years). During routine examinations, sputa were retained from older patients, and oropharyngeal swabs from patients younger than six years. Among these patients were two pairs of siblings. Three siblings were in one family, two of whom were twins.
Species identifi cation and antifungal drug susceptibility testing
Yeast isolates were cultured on Sabouraud-agar without additional antibiotics. The species were identifi ed by morphology on CHROMagar Candida (CHROMagar, Paris, France) plates and through use of the API 32C-system (bioMérieux, Nürtingen, Germany). To differentiate C. albicans and C. dubliniensis , C. albicans isolates were streaked on Staib-agar [ 4 ] .
In vitro susceptibility to amphotericin B (AMB), fl ucytosine (5FC), fl uconazole (FLC), itraconazole (ITC), voriconazole (VRC) and micafungin (MFG) was tested by a microbroth dilution method in accordance with the recommendations of the CLSI M27-2A document with minor modifi cations [ 5 ] . The medium used for susceptibility testing was high resolution (HR) antifungal assay medium (Oxoid, Wesel, Germany), the standard medium for susceptibility testing in Germany [ 6 ] . The MIC endpoints of FLC, 5FC, ITC, VRC and MFG were determined by spectrophotometrically measuring at 650 nm the lowest concentration with more than 50% inhibition relative to the growth control. The MICs of AMB were determined as the lowest concentration with no visible growth. C. albicans ATCC #90028, C. glabrata ATCC #90030, C. parapsilosis ATCC #22013, C. krusei ATCC #6258, C. dubliniensis CBS #7987 , C. tropicalis CBS #94 T and C. lusitaniae CBS #5901 were carried along as control strains in every run.
Biotyping
Southern blot hybridization was performed with the CARE-2 probe ( C. albicans specifi c repetitive element 2) [ 7 ] . Genomic DNA was extracted using phenol/ chloroform and isopentylalcohol. The concentration was measured photometrically after cleaning and RNA digestion. A 930 bp CARE-2 fragment was amplifi ed by PCR. Ten μg of chromosomal DNA was digested with 1μl Eco RI and an electrophoresis was performed. After UV cross-linking on a nylon membrane, the fi lter was hybridized with chemiluminescent-labeled CARE-2 DNA (Enzo Amersham Pharmacia Biotech, Buckinghamshire, UK). Detection of the hybridization results was performed with detection-solution according to the manufacturer's instructions. The chemiluminescent light signal was captured on a radiologic fi lm.
Biotyping of other Candida spp. was performed using arbitrarily-primed PCR (AP-PCR) by use of primer RP02 (5´GCGATCCCCA3´) in the PCR experiments (annealing 1 min, 37°C; elongation 2 min, 72°C). The DNA concentration used was 0.02 μg/μl. The PCR product was separated with an 1% agarose gel which was then dyed for 10 min in an ethidiumbromide bath and documented with Geldoc (Bio-Rad, Hercules, USA) [ 8, 9 ] .
Banding patterns of consecutive patient isolates were analyzed for their relatedness with computer-assisted similarity calculations based on standardized banding pattern analysis and the subsequent construction of dendrograms [ 10 ] . The methods of Schmid et al . were employed [ 11 ] . Southern blots of the different isolates were compared using the Gelscan (bioscitec, Frankfurt/Main, Germany, version 5.1) software. The similarity coeffi cient (S AB ) was based on band position for every pair of isolates of one patient according to the formula S AB ϭ2n AB /(n A ϩn B ) , where n AB is the number of bands that is common for strain A and B , n A is the total number of bands in strain A and n B is the total number of band in strain B. The threshold for close relation (SAB Ն 0.83) was in accordance with previous studies [ 10 ] . For statistics, the Gelscan program uses the dice coeffi cient, a correlation coeffi cient for discrete events. Dice(x, y)ϭ2 P(x, y)/(P(x)ϩP(y)). Here P(x) and P(y) are the probability for event x or y appear separately; P(x, y) is the probability for event x and y appear together. If the patterns are identical, the S AB is equal to 1.00. If one or more bands differ in size and/or intensity, there is a gradation of S AB from 0.99 to 0.01, with decreasing similarity. An S AB of 0.00 indicates that no bands in two patterns are of the same size. For the generation of a dendrogram, the program identifi es fi rst the two strains with the highest S AB value and groups them into a unit with a branching point corresponding to their S AB . The program then searches again for the strain-strain or strain-unit pair with the highest S AB and connects it. The process continues until all isolates are connected.
Results
A total of 422 Candida isolates were recovered from sputa or oropharyngeal swabs of 56 CF patients during the 30-month study period. Depending of the timeframe of each patient, a mean of 5.3 (range 1-21) isolates were found in the respiratory samples, of which 332 (78.8%) from 53 patients were identifi ed as C. albicans. The three other most frequent Candida spp. found in specimens were; C. glabrata (31 isolates from 9 patients), C. dubliniensis (22 isolates from 7 patients) and C. parapsilosis (20 isolates from 6 patients). Other less frequently encountered Candida spp. were; C. tropicalis (6 isolates in 2 patients), C. kefyr (4 isolates in 2 patients), C. lusitaniae and C. krusei (both isolates recovered from 1 patient), C. rugosa and C. pelliculosa (both in 1 patient). Seven out of the 22 isolates were identifi ed as C. dubliniensis as refl ected by a lack of hybridization with the CARE-2 probe ( Fig. 1 ) . Overall, only one species was isolated (mostly C. albicans ) from 67% of the patients, as contrasts with two species in 18% of the cases, 3 in 11% and four different species found in 4% of the cases. Over a longer period of time, only one patient showed persistence of a single Candida spp., with the average persistence of any species ranging from 8-18 months. Computer-assisted similarity calculations demonstrated that each patient with more than 8 isolates had closely related strains (calculated by the Dice coeffi cient/ S AB Ն 0.83) ( Table 1 ). Hybridization and PCR results of samples from one representative patient are shown in Figs. 1 and 2 . Fig. 3 demonstrates the relatedness of 12 C. albicans isolates obtained from one patient over an 18-month period. Nine isolates were closely related as indicated by a S AB value Ն 0.83, but two C. albicans strains isolated in month 5 and 7 were not closely related to the others (S AB Ͻ valueS 0.83).
Transmission of closely related C. albicans strains between siblings occurred in a pair of siblings (patient 35ϩ30) and in a triplet of siblings (patient 7ϩ8ϩ16) ( Table 2 ) . Fig. 4 displays the relatedness of the isolates of a sibling triplet. Sibling A's isolates, obtained over a period of 24 months, were all closely related. The isolates of the other two siblings were obtained in the fi rst quarter of the fi rst year. These isolates were also closely related to sibling A's isolates. However, sibling B and C isolates were not closely related (S AB value Ͻ 0.83).
Of all C. albicans isolates, 90% were susceptible to AMB, 5FC, FLC, ITC, VRC and MFG. Ten isolates of C. albicans , nine of them from a single patient, demonstrated slightly elevated MICs for 5FC in comparison to the control strain without previous antifungal treatment in the patient's history. In one patient, fi ve isolates were resistant to FLC and ITC, whereas four were crossresistant to all azoles. Three additional isolates from this patient, who had not been previously treated with antifungals, had elevated MICs for FLC and ITC. All C . dubliniensis isolates were susceptible to AMB, 5FC, FLC, ITC, VRC and MFG. C. parapsilosis was less susceptible to MFG but susceptible to all other tested antifungals. Five of six isolates of C. tropicalis were cross-resistant to FLC, ITCand VRC. One isolate was susceptible to FLC, but resistant to ITC (MIC FLC 4 μg/ ml, ITC 2 μg/ml, VRC 0.12 μg/ml). Of 24 tested C. glabrata isolates, 20 demonstrated elevated MICs to FLC, 12 of them were dose-dependent susceptible. Eight of these isolates also demonstrated reduced susceptibility to ITC, but not to VRC ( Table 3 ) .
Discussion
The frequent use of antibiotics, oral and inhaled steroids predisposes CF patients to oral colonization by Candida spp. C. albicans was isolated from the respiratory tract in 93% of CF patients, whereas other Candida spp. were recovered from 20% these individuals. An increase in the emergence of other Candida spp. ensis was cultured repeatedly over a longer period of time (average 12 months). Hydrophobicity could play an important role in virulence because of the resulting diffi culties in phagocytosis and the dehydrated sputum in the respiratory tract [ 3 ] . In the study of Peltroche-Llacsahuanga, 5 of 6 patients (mean age of 20 years) were infected with C. dubliniensis , whereas younger patients (mean age of 12.4 years) were colonized with C. dubliniensis in this study. One limitation of the study was that rather than sputa, deep oropharyngeal swabs were used in younger children with CF. Therefore, isolated Candida spp. in this group may not exclusively represent the lower airways, but the oral cavity as well. However, this is the best approach in younger children as has been previously demonstrated [ 3 ] . Additionally, a further limitation was that after isolating the yeast, only one colony was selected for the biotyping studies. Due to the high number of samples it was impossible to perform random selection of colonies. This may have led to sampling bias as only one strain (perhaps the most predominant) was selected for biotyping. The variation in persistence of different Candida spp. was dependent on the species, the number of isolates of this species, the different examination periods of the patients and the date of the fi rst isolation. The persistence observation of Candida spp. in the respiratory tract of CF patients confi rmed previous fi ndings in which chronic colonization of CF-patients by C. albicans was reported [ 14 ] .
Since 2001, many different typing methods have been described, e.g., microsatellite typing, SNP typing or MLST. The C. albicans specifi c CARE-2 probe was has been reported in the literature, which could be the result of an enhanced ability to differentiate members of this genus and perhaps, their ability to develop resistance to antifungals [ 12 ] . In a study by Doern et al ., the non-C. albicans Candida spp. accounted for 15% of all Candida isolates. The most frequent non-C. albicans Candida spp. found were C. tropicalis (6%) , C. glabrata (5%) and C. parapsilosis (4%) [ 13 ] . In contrast, we found that C. tropicalis was only 1% of the isolates found in patient specimens. The prevalence of C. parapsilosis (4%) and C. glabrata (7%) was similar to the recovery reported by Doern et al . [ 13 ] . PeltrocheLlacsahuanga et al . investigated the prevalence of C. dubliniensis in CF patients and reported a colonization rate of 11%, which is similar to our fi ndings [ 3 ] . This yeastlike fungus was recovered from the sputa of seven of our patients (12.5%) and in four of them, C. dublini of highly related strains over a longer period. The average S AB value of 0.66 is very close to that calculated in similar studies, although the latter were performed partly with another repetitive element (Ca3) [ 11 ] . In spite of the different genotypic identifi cation during the observation period, the analysis of samples from patients with more than eight isolates resulted in very similar banding patterns with a similarity coeffi cient (S AB ) Ն 0.83, indicating a higher probability of relatedness. In most cases closely related strains were isolated over the entire observation period. Closely related strains persisted over 18 months in one representative patient ( Fig. 3 ) , who was infected by a second strain in months 5 and 7. After 2 months this second strain was eradicated, but the fi rst strain persisted. It is therefore likely that minor genetic changes to the hostmilieu took place. This phenomenon of 'microevolution' or 'substrain-shuffl ing' has been described several times [ 8 ,15, 16 ] . These results indicate that spontaneous changes in strains do not occur as often as previously reported employed in our investigation as it is a well established typing method in our lab [ 9 ] . In this study, closely related strains were observed among patients with more than one isolate of the same species by CARE-2 and RAPD. Fingerprinting techniques refl ect genetic relatedness among isolates and each method has advantages and disadvantages. Common drawbacks are the potential lack of homology, which can be assessed only by sequencing, and the possibility of homoplasy. To avoid these problems, it is recommended to use at least two different techniques when a perfect match between two isolates should be found [ 9 ] . This strategy was only done with C. albicans strains in this study due to the high number of samples. The overall persistence of closely related C. albicans was 16.4 months. The biotyping of the other Candida spp. was limited due to the large amount of strains ( n ϭ 422) by the use of only one method. By biotyping, consecutive isolates of patients were analyzed for relatedness of the banding patterns based on computer-assisted standardized analysis to assess persistence 5FC although this patient had not been treated previously with antifungals. Therefore, we suppose that these isolates were naturally resistant to 5FC [ 14 ] . Another patient's isolate demonstrated cross-resistance to all tested azoles. This individual had also not been treated previously with an antifungal. It's possible that these isolates were naturally resistant to FLC [ 14 ,19 ] . C. dubliniensis may develop azole-resistance after long-term treatment with FLC [ 8 ,20 ] , but we did not fi nd such results. Intrinsic azole-resistance of C. glabrata is well-known and has often been reported [ 21, 22 ] . In this study, resistance of C. glabrata against common azoles could be demonstrated in the majority of cases. The development of azole resistance by C. glabrata is a process involving multiple molecular mechanisms that
have not yet been completely investigated. All C. glabrata isolates were susceptible to the next-generation triazole VRC. In the case of one patient that had been treated with ITC, it is possible that this caused the resistance. All isolates of C. tropicalis tested in this study demonstrated reduced susceptibility to the three azoles FLC, ITC and VRC. Resistance of C. tropicalis against azole antifungals has already been reported [ 19 ,23 ] . Natural resistance of C. tropicalis against azole-antifungals has been observed before in patients with no history of treatment with azoles [ 15, 17 ] . With regard to the long-term persistence, eradication of a persistent Candida strain could be of benefi t for individual CF patients with pulmonary exacerbations. Transmission of related C. albicans strains between siblings was demonstrated in two families in this study. Transmission of yeasts among siblings, both of whom were suffering from CF, has not been reported thus far. Mueller et al . noted the transmission of an azole-resistant isogenic C. albicans strain from children who had been poorly treated with azole-antifungals to their mother [ 18 ] . The dendrogram in a triplet of siblings displayed clusters that showed that closely related strains were found between sibling B and A in the fi rst month and between sibling C and A in the third month. Surprisingly a close relation between C. albicans strains of sibling B and C was not observed (S AB Ͻ 0.83). Therefore, we hypothesize that the siblings B and C were infected by sibling A. The results of this study demonstrate that transmission of yeasts among CF patients can occur. The C. lusitaniae, C. kefyr, C. rugosa and C. dubliniensis isolates were susceptible to AMB, FLC, ITC, VRC, 5FC and MFG, whereas all C. albicans isolates were susceptible to AMB and MFG. One patient was colonized with several C. albicans isolates with reduced susceptibility to [ 19 ] . But despite this, a trailing growth was reported that may cause a modifi cation in microdilution assays [ 25 ] . C. parapsilosis showed reduced susceptibility to the echinocandin MFG. The observation of higher in vitro MICs with the echinocandins caspofungin and MFG has been reported [ 26 ] . However, fi rst reports from clinical trials indicate that this might be an in vitro phenomenon, since caspofungin and other echinocandins were active against C. parapsilosis in vivo [ 27 ,28 ] . Additionally, it has to be discussed if this mixed species fl ora can also affect the MIC testing. Further studies are warranted to investigate if long-term persistence of Candida spp. in the respiratory tract of CF patients is more often associated with chronic infection and infl ammation in the lungs, and whether antifungal treatment for patients with long-term persistence of closely related strains might be benefi cial. Additionally, the often found mixed species fl ora in CF has to be investigated in more detail. Antifungal drug resistance was rather low in the study population, but may occur in single previously untreated CF patients, and therefore requires further attention. Transmission of closely related Candida strains among siblings with CF can occur and may require specifi c prevention strategies.
